Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Value propositions in future pharmaceutical benefits.

F Randy Vogenberg1

  • 1Aon Consulting, Health System Education and Pharmaceutical Consulting, Wellesley, Massachusetts, USA.

Employee Benefits Journal
|September 11, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Return to Business During a Pandemic: Market Collaboration and Health Benefit Trends.

American health & drug benefits·2020
Same author

Key Trends in Healthcare for 2020 and Beyond.

American health & drug benefits·2020
Same author

From Then Until Now: A Top-Down View Of The Affordable Care Act.

P & T : a peer-reviewed journal for formulary management·2019
Same author

Beyond Medical Cannabis: Considerations for Updates to Hospital Policies and Procedures.

P & T : a peer-reviewed journal for formulary management·2019
Same author

As Health Care Landscape Shifts, Stakeholders Need To Shift as Well.

Managed care (Langhorne, Pa.)·2019
Same author

Regulatory and Legislative Disparities With Cannabis Present Challenges to P&T Committees and Health Care Providers.

P & T : a peer-reviewed journal for formulary management·2019

Benefit managers face new diagnostics and drugs, requiring updated drug benefit planning. Strategic planning involves understanding value propositions, trends, and the drug pipeline.

Area of Science:

  • Pharmacoeconomics
  • Health Services Research
  • Pharmaceutical Policy

Background:

  • The pharmaceutical landscape is rapidly evolving with novel diagnostics and therapeutics.
  • Benefit managers must adapt drug benefit plans to incorporate these advancements.
  • Anticipating future drug development is crucial for effective healthcare resource allocation.

Purpose of the Study:

  • To provide benefit managers with insights into upcoming changes in drug benefit planning.
  • To outline key value propositions and considerations for evaluating new pharmaceuticals.
  • To highlight essential trends and the drug development pipeline impacting benefit design.

Main Methods:

  • Review of current pharmaceutical trends and pipeline analysis.
  • Identification of critical value propositions for new drug assessments.

Related Experiment Videos

  • Synthesis of expert insights and strategic planning considerations.

    • Main Results:

    • Emerging diagnostics and drugs necessitate a re-evaluation of existing benefit structures.
    • Key value propositions include clinical efficacy, patient access, and economic impact.
    • Awareness of the drug pipeline and market trends is paramount for proactive planning.

    Conclusions:

    • Benefit managers must proactively engage with the evolving pharmaceutical market.
    • Strategic benefit planning requires integrating pipeline intelligence and expert knowledge.
    • Adaptability in drug benefit design is essential for managing future healthcare costs and outcomes.